Tiedemann Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.85M Buy
5,308
+4,739
+833% +$2.44M 0.12% 65
2023
Q2
$267K Buy
+569
New +$239K 0.01% 213
2021
Q3
Sell
-7,092
Closed -$1.63M 339
2021
Q2
$1.63M Sell
7,092
-544
-7% -$109K 0.07% 125
2021
Q1
$1.43M Buy
7,636
+138
+2% +$27K 0.06% 129
2020
Q4
$1.27M Buy
7,498
+82
+1% +$12.2K 0.06% 130
2020
Q3
$1.1M Sell
7,416
-2
-0% -$310 0.05% 167
2020
Q2
$1.22M Sell
7,418
-5
-0.1% -$767 0.06% 153
2020
Q1
$1.03M Buy
7,423
+712
+11% +$97.8K 0.07% 151
2019
Q4
$882K Sell
6,711
-1,062
-14% -$123K 0.04% 173
2019
Q3
$871K Sell
7,773
-65
-0.8% -$7.24K 0.04% 184
2019
Q2
$867K Sell
7,838
-2,700
-26% -$318K 0.04% 164
2019
Q1
$1.37M Buy
10,538
+167
+2% +$20.3K 0.06% 178
2018
Q4
$1.2M Buy
10,371
+7,808
+305% +$872K 0.06% 185
2018
Q3
$275K Sell
2,563
-97
-4% -$9.7K 0.02% 266
2018
Q2
$228K Buy
+2,660
New +$218K 0.01% 278
2017
Q3
Sell
-9,188
Closed -$756K 408
2017
Q2
$756K Buy
9,188
+1,664
+22% +$136K 0.06% 255
2017
Q1
$633K Buy
+7,524
New +$603K 0.05% 238

Other funds holding LLY

Tiedemann Advisors's LLY Position: Q3 2023 in Review

Tiedemann Advisors increased its Eli Lilly (LLY) stake by 833% in Q3 2023, buying an estimated $2.44M and bringing the position to 5,308 shares worth $2.85M. The position accounts for 0.12% of the portfolio, ranked #65.

Tiedemann Advisors first reported a position in LLY in Q1 2017 and has held it in 17 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • Tiedemann Advisors held 5,308 shares of Eli Lilly worth $2.85M as of Q3 2023.
  • Tiedemann Advisors bought 4,739 Eli Lilly shares in Q3 2023, an estimated $2.44M.
  • Eli Lilly made up 0.12% of Tiedemann Advisors's portfolio in Q3 2023, its #65 holding.
  • Tiedemann Advisors first reported a position in Eli Lilly in Q1 2017 and has held it in 17 quarters since.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Tiedemann Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.